Derivative exercise or conversion — not an open-market buy.
Traded May 13, 2026 · Filed May 13, 2026
The money chief of TKO Group Holdings spent $186K of their very own money to buy TKO Group Holdings shares. 3 other people at TKO Group Holdings bought some too, in the same month.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market purchase
Code P — open-market or private purchase
~$186,210
Shares × reported transaction price
$100K–$500K
+3.4%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
4 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
This purchase equals less than 1% of the average reported total pay of the company's named executive officers other than the CEO, fiscal 2025 ($25.3M)
An average across the officers named in the pay versus performance table of the company's proxy statement (DEF 14A), filed 2026-04-23. This person may not be one of them, so it is not their own pay. A size comparison, not a judgement
7 days after results of May 6, 2026, 82 days before results of Aug 3, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $183.70 on May 13, 2026, 18% above its 52-week low and 18% below its high, after a 9% drop over the previous 30 trading days
52-week range $155.61 (Aug 6, 2025) to $224.96 (Mar 2, 2026), 41% of the way up, from 251 adjusted closes. 30 trading days earlier: $201.65 on Mar 31, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -0.5% | -0.7% | +0.3% |
| 30 days | +4.5% | +0.9% | +3.6% |
| 90 days | +1.4% | +3.3% | -1.9% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Compensation award — excluded from discretionary-purchase analysis.